Company Filing History:
Years Active: 2024
Title: Annika Birgitta Margareta Åstrand: Innovator in Pharmaceutical Chemistry
Introduction
Annika Birgitta Margareta Åstrand is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of selective inhibitors.
Latest Patents
Annika Åstrand holds a patent for JAK1 selective inhibitors. The patent discloses compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein R-R have any of the meanings defined in the patent. Additionally, it includes pharmaceutical compositions comprising these compounds and methods of using them.
Career Highlights
He is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work focuses on innovative solutions in drug development, contributing to advancements in medical treatments.
Collaborations
Annika has collaborated with esteemed colleagues, including Karl Magnus Nilsson and Anna Ingrid Kristina Berggren, to further enhance the research and development of pharmaceutical compounds.
Conclusion
Annika Birgitta Margareta Åstrand is a prominent figure in the pharmaceutical industry, recognized for his innovative work and contributions to drug development. His patent on JAK1 selective inhibitors exemplifies his commitment to advancing medical science.